Period of time： 2014年9期
Publisher： Informa Healthcare
Founded in： 2006
Total resources： 77
ISSN： 1746-0441
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Discovery,volume 2,issue 9
Menu
Access to resources
Recommend
Novel 8-heterocyclyl xanthine derivatives in drug development – an update
By Baraldi Pier G,Fruttarolo Francesca,Tabrizi Mojgan A,Romagnoli Romeo,Preti Delia in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.Nicotinic receptors as targets for therapeutic discovery
By Lippiello PM,Bencherif M,Hauser TA,Jordan KG,Letchworth SR,Mazurov AA in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.Characterisation of aptamers for therapeutic studies
By Wochner Aniela,Menger Marcus,Rimmele Martina in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discovery
By Mandel Silvia,Amit Tamar,Kalfon Limor,Youdim Moussa BH in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.Atherosclerosis imaging in drug development
By Nicholls Stephen J,Kalidindi Srinivasa,Moon Keon-Woong,Nissen Steven E in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.Drug discovery for hyperuricemia
By Anzai Naohiko,Endou Hitoshi in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.The design and development of drugs acting against the smallpox virus
By Omari Kamel El,Stammers David K in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 9 , Vol. 2, Iss. 9, 2007-09 , pp.